These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30288409)

  • 1. Data-Driven Markov Decision Process Approximations for Personalized Hypertension Treatment Planning.
    Schell GJ; Marrero WJ; Lavieri MS; Sussman JB; Hayward RA
    MDM Policy Pract; 2016; 1(1):2381468316674214. PubMed ID: 30288409
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamic treatment selection and modification for personalised blood pressure therapy using a Markov decision process model: a cost-effectiveness analysis.
    Choi SE; Brandeau ML; Basu S
    BMJ Open; 2017 Nov; 7(11):e018374. PubMed ID: 29146652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From data to optimal decision making: a data-driven, probabilistic machine learning approach to decision support for patients with sepsis.
    Tsoukalas A; Albertson T; Tagkopoulos I
    JMIR Med Inform; 2015 Feb; 3(1):e11. PubMed ID: 25710907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markov Decision Process Modeling for Multi-stage Optimization of Intervention and Treatment Strategies in Breast Cancer.
    Imani F; Qiu Z; Yang H
    Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():5394-5397. PubMed ID: 33019200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound Poisson and Poisson process approximations for occurrences of multiple words in Markov chains.
    Reinert G; Schbath S
    J Comput Biol; 1998; 5(2):223-53. PubMed ID: 9672830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategic level proton therapy patient admission planning: a Markov decision process modeling approach.
    Gedik R; Zhang S; Rainwater C
    Health Care Manag Sci; 2017 Jun; 20(2):286-302. PubMed ID: 26810359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid approximation of confidence intervals for Markov process decision models: applications in decision support systems.
    Cher DJ; Lenert LA
    J Am Med Inform Assoc; 1997; 4(4):301-12. PubMed ID: 9223036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Markovian decision model of adaptive cancer treatment and quality of life.
    Bayer P; Brown JS; Dubbeldam J; Broom M
    J Theor Biol; 2022 Nov; 551-552():111237. PubMed ID: 35944591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markov decision processes: a tool for sequential decision making under uncertainty.
    Alagoz O; Hsu H; Schaefer AJ; Roberts MS
    Med Decis Making; 2010; 30(4):474-83. PubMed ID: 20044582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized treatment planning with a model of radiation therapy outcomes for use in multiobjective optimization of IMRT plans for prostate cancer.
    Smith WP; Kim M; Holdsworth C; Liao J; Phillips MH
    Radiat Oncol; 2016 Mar; 11():38. PubMed ID: 26968687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Markov decision process approach to multi-category patient scheduling in a diagnostic facility.
    Gocgun Y; Bresnahan BW; Ghate A; Gunn ML
    Artif Intell Med; 2011 Oct; 53(2):73-81. PubMed ID: 21726988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantile Markov Decision Processes.
    Li X; Zhong H; Brandeau ML
    Oper Res; 2022; 70(3):1428-1447. PubMed ID: 36034163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scalable approximate policies for Markov decision process models of hospital elective admissions.
    Zhu G; Lizotte D; Hoey J
    Artif Intell Med; 2014 May; 61(1):21-34. PubMed ID: 24791675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity Analysis in Sequential Decision Models.
    Chen Q; Ayer T; Chhatwal J
    Med Decis Making; 2017 Feb; 37(2):243-252. PubMed ID: 27681992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Information Collection Policies in a Markov Decision Process Framework.
    Cipriano LE; Goldhaber-Fiebert JD; Liu S; Weber TA
    Med Decis Making; 2018 Oct; 38(7):797-809. PubMed ID: 30179585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis.
    Montgomery AA; Fahey T; Ben-Shlomo Y; Harding J
    J Hypertens; 2003 Sep; 21(9):1753-9. PubMed ID: 12923409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approximate robust policy iteration using multilayer perceptron neural networks for discounted infinite-horizon Markov decision processes with uncertain correlated transition matrices.
    Li B; Si J
    IEEE Trans Neural Netw; 2010 Aug; 21(8):1270-80. PubMed ID: 20601311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence framework for simulating clinical decision-making: a Markov decision process approach.
    Bennett CC; Hauser K
    Artif Intell Med; 2013 Jan; 57(1):9-19. PubMed ID: 23287490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDPs with Non-Deterministic Policies.
    Fard MM; Pineau J
    Adv Neural Inf Process Syst; 2009; 21():1065-1073. PubMed ID: 21625292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model.
    Moise N; Huang C; Rodgers A; Kohli-Lynch CN; Tzong KY; Coxson PG; Bibbins-Domingo K; Goldman L; Moran AE
    Hypertension; 2016 Jul; 68(1):88-96. PubMed ID: 27181996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.